Join

Compare · LFST vs OPCH

LFST vs OPCH

Side-by-side comparison of LifeStance Health Group Inc. (LFST) and Option Care Health Inc. (OPCH): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both LFST and OPCH operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
  • OPCH is the larger of the two at $3.21B, about 1.1x LFST ($2.85B).
  • Over the past year, LFST is up 34.2% and OPCH is down 38.9% - LFST leads by 73.1 points.
  • OPCH has been more active in the news (11 items in the past 4 weeks vs 7 for LFST).
  • LFST has more recent analyst coverage (16 ratings vs 14 for OPCH).
PerformanceLFST+34.18%OPCH-38.88%
2025-05-07+0.00%2026-05-06
MetricLFSTOPCH
Company
LifeStance Health Group Inc.
Option Care Health Inc.
Price
$7.38+0.41%
$20.45-3.99%
Market cap
$2.85B
$3.21B
1M return
+14.77%
-26.32%
1Y return
+34.18%
-38.88%
Industry
Medical/Nursing Services
Medical/Nursing Services
Exchange
NASDAQ
NASDAQ
IPO
2021
News (4w)
7
11
Recent ratings
16
14
LFST

LifeStance Health Group Inc.

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. The company offers patients care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was incorporated in 2021 and is based in Scottsdale, Arizona.

OPCH

Option Care Health Inc.

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.

Latest LFST

Latest OPCH